Entering text into the input field will update the search result below

Pfizer, Inc. (PFE) CEO Albert Bourla on Q1 2022 Results - Earnings Call Transcript

May 03, 2022 7:15 PM ETPfizer Inc. (PFE)1 Comment
SA Transcripts profile picture
SA Transcripts

Pfizer, Inc. (NYSE:PFE) Q1 2022 Earnings Conference Call May 3, 2022 10:00 AM ET

Company Participants

Christopher Stevo - SVP & Chief IR Officer

Albert Bourla - Chairman & CEO

Mikael Dolsten - Chief Scientific Officer & President, Worldwide Research, Development & Medical

Frank D'Amelio - CFO

Aamir Malik - EVP & Chief Business Innovation Officer

William Pao - EVP & Chief Development Officer

Angela Hwang - Group President of Biopharmaceuticals Group

Conference Call Participants

Louise Chen - Cantor Fitzgerald & Co.

Evan Seigerman - BMO Capital Markets

Mohit Bansal - Wells Fargo Securities

Terence Flynn - Morgan Stanley

Stephen Scala - Cowen and Company

Carter Gould - Barclays Bank

Alexandria Hammond - Bank of America Merrill Lynch

Timothy Anderson - Wolfe Research

Robyn Karnauskas - Truist Securities

Vamil Divan - Mizuho Securities

Christopher Schott - JPMorgan Chase & Co.

Kerry Holford - Berenberg

Colin Bristow - UBS

Andrew Baum - Citigroup


Good day, everyone, and welcome to Pfizer's First Quarter 2022 Earnings Conference Call. Today's call is being recorded. At this time, I would like to turn the call over to Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.

Christopher Stevo

Thank you, operator. Good morning. Welcome to Pfizer's first quarter earnings call. I'm joined today by Dr. Albert Bourla, our Chairman and CEO; Frank D'Amelio, our CFO; and Mikael Dolsten, President of Worldwide Research and Development and Medical. Joining us for the Q&A session, we will also have Angela Hwang, Group President, Pfizer Biopharmaceuticals Group; Aamir Malik, our Chief Business and Innovation Officer; Doug Lankler, our General Counsel; and William Pao, our new Chief Development Officer.

The materials for this call and other earnings-related materials are on the Investor Relations section of pfizer.com. Please see our forward-looking statements disclaimer on Slide 3

Recommended For You

Comments (1)

Funny that Covid was 95% of the CC. Must be the only bullet they have left in the gun.
To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.